Advances in the treatment of advanced melanoma with NRAS gene mutation
Oncogenic mutations are responsible for a majority of the malignancy of melanoma. Activating mutations of NRAS gene are found in 15%-20% melanoma cases, endowing the tumor cells with more aggressive phenotypes and greater difficulty to treat. The development of targeted inhibitor of mutant NRAS rema...
Uloženo v:
| Hlavní autor: | |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Editorial Office of China Oncology
2023-10-01
|
| Edice: | Zhongguo aizheng zazhi |
| Témata: | |
| On-line přístup: | http://www.china-oncology.com/fileup/1007-3639/PDF/1698723448742-951764022.pdf |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|